Singapore: Australia-based drug giant, Mayne pharma has reportedly filed an application seeking rights to produce and ma...
Singapore: After a recent inspection of Hospira's Melbourne based facility, FDA has labelled the pharma giant's drugs as...
Singapore: The US-based Novavax recently announced that it has begun human trials for its Ebola vaccine shot. The devel...
As per the estimates, currently, there are more than 36 million people living with dementia worldwide. Further, it is ...
Singapore: Algae.Tec, an advanced algae to biofuels company, has opened a new facility Shoalhaven One at Nowra, south of...
Singapore: Australia-based Prima BioMed has announced the acquisition of France-based Immutep, a private biopharmaceutic...
Singapore: Colorectal Cancer (CRC) therapeutics market in Asia-Pacific (APAC) is set to increase in value, from $1.9 bil...
Singapore: Patrys received approval to progress its phase I/IIa PAT-SM6 multiple myeloma trial based on safety data from...
Singapore: The global private equity firm, Riverside Company has said that it would be investing about $100 million in A...
Singapore: A new health and medical equipment division has been launched by global technology giant, Samsung, in Austral...
Singapore: Cytomedix's Angel cPRP System has been listed by the TGA (Therapeutic Goods Administration) in Australia. Fo...
Singapore: Genea Stem Cells (GSC), a supplier and developer of disease-specific human stem cells, announced that 25 of ...
Singapore: OccuRx, an Australian biopharmaceutical company developing a new class of drugs to prevent health burden due ...
Singapore: Non-Hodgkin Lymphoma (NHL) treatment market in Asia-Pacific (APAC) countries including India, Australia, Chin...
Singapore: Novartis has agreed to sell its influenza vaccines business to Australia's CSL, a blood products and vaccines...
Singapore: A group of international researchers, including from University of Melbourne, have discovered a new class of ...
Singapore: Prana Biotechnology announced the upcoming presentation of new data demonstrating the ability of PBT2 to redu...
Singapore: Australia-based startup company Sienna Cancer Diagnostics, has inked a pact with an American pathology compan...
